Cargando…

Pro-resolving lipid mediator Resolvin D1 serves as a marker of lung disease in cystic fibrosis

BACKGROUND: Cystic fibrosis (CF) is an autosomal recessive genetic disorder that affects multiple organs, including the lungs, pancreas, liver and intestine. Mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) locus lead to defective proteins and reduced Cl(-) secretion and N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eickmeier, Olaf, Fussbroich, Daniela, Mueller, Klaus, Serve, Friederike, Smaczny, Christina, Zielen, Stefan, Schubert, Ralf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5291435/ https://www.ncbi.nlm.nih.gov/pubmed/28158236 http://dx.doi.org/10.1371/journal.pone.0171249

Ejemplares similares

Connexin 37 and Connexin 43 genotypes in correlation to cytokines in induced sputum and blood in cystic fibrosis (CF)
por: Ludwig, M, et al.
Publicado: (2014)

A combination of LCPUFA ameliorates airway inflammation in asthmatic mice by promoting pro-resolving effects and reducing adverse effects of EPA
por: Fussbroich, D., et al.
Publicado: (2020)

Impact of a Gap Junction Protein Alpha 4 Variant on Clinical Disease Phenotype in F508del Homozygous Patients With Cystic Fibrosis
por: Horn, Tabea, et al.
Publicado: (2020)

Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis
por: Philippe, Réginald, et al.
Publicado: (2018)

Impact of CFTR Modulators on the Impaired Function of Phagocytes in Cystic Fibrosis Lung Disease
por: Meoli, Aniello, et al.
Publicado: (2022)

A specific combined long-chain polyunsaturated fatty acid supplementation reverses fatty acid profile alterations in a mouse model of chronic asthma
por: Fussbroich, D., et al.
Publicado: (2019)

Oxidative stress-driven pulmonary inflammation and fibrosis in a mouse model of human ataxia-telangiectasia
por: Duecker, Ruth, et al.
Publicado: (2017)

Pro-Resolving Lipid Mediator Resolvin E1 Mitigates the Progress of Diethylnitrosamine-Induced Liver Fibrosis in Sprague-Dawley Rats by Attenuating Fibrogenesis and Restricting Proliferation
por: Rodríguez, Maria José, et al.
Publicado: (2020)

Transforming Growth Factor β1 Genotypes in Relation to TGFβ1, Interleukin-8, and Tumor Necrosis Factor Alpha in Induced Sputum and Blood in Cystic Fibrosis
por: Eickmeier, O., et al.
Publicado: (2013)

Stereoselective Synthesis and Structural Confirmation of the Specialized Pro-Resolving Mediator Resolvin E4
por: Reinertsen, Amalie Føreid, et al.
Publicado: (2021)

Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis
por: Recchiuti, Antonio, et al.
Publicado: (2019)

Candida albicans Modulates Host Defense by Biosynthesizing the Pro-Resolving Mediator Resolvin E1
por: Haas-Stapleton, Eric J., et al.
Publicado: (2007)

The Role of Specialized Pro-Resolving Mediators in Cystic Fibrosis Airways Disease
por: Briottet, Maelle, et al.
Publicado: (2020)

Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score
por: Mainz, Jochen G., et al.
Publicado: (2022)

Resolvin D1 Reduces Lung Infection and Inflammation Activating Resolution in Cystic Fibrosis
por: Isopi, Elisa, et al.
Publicado: (2020)

Protective role of resolvin D1, a pro-resolving lipid mediator, in nonsteroidal anti-inflammatory drug-induced small intestinal damage
por: Kuzumoto, Takuya, et al.
Publicado: (2021)

Corrigendum: Elexacaftor-Tezacaftor-Ivacaftor treatment reduces abdominal symptoms in cystic fibrosis-early results obtained with the CF-specific CFAbd-Score
por: Mainz, Jochen G., et al.
Publicado: (2023)

Pro-Resolving Effects of Resolvin D(2) in LTD(4) and TNF-α Pre-Treated Human Bronchi
por: Khaddaj-Mallat, Rayan, et al.
Publicado: (2016)

Total synthesis of the endogenous inflammation resolving lipid resolvin D2 using a common lynchpin
por: Li, John, et al.
Publicado: (2013)

The Chitinase-Like Protein YKL-40 Modulates Cystic Fibrosis Lung Disease
por: Hector, Andreas, et al.
Publicado: (2011)

High levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactation
por: Weiss, Gisela Adrienne, et al.
Publicado: (2013)

Molecular Epidemiology of Mycobacterium abscessus Isolates Recovered from German Cystic Fibrosis Patients
por: Wetzstein, Nils, et al.
Publicado: (2022)

Resolvins, Protectins, and Maresins: DHA-Derived Specialized Pro-Resolving Mediators, Biosynthetic Pathways, Synthetic Approaches, and Their Role in Inflammation
por: Ferreira, Inês, et al.
Publicado: (2022)

Impact of elexacaftor/tezacaftor/ivacaftor on lung function, nutritional status, pulmonary exacerbation frequency and sweat chloride in people with cystic fibrosis: real-world evidence from the German CF Registry
por: Sutharsan, Sivagurunathan, et al.
Publicado: (2023)

A Novel Anti-Inflammatory and Pro-Resolving Role for Resolvin D1 in Acute Cigarette Smoke-Induced Lung Inflammation
por: Hsiao, Hsi-Min, et al.
Publicado: (2013)

382: SARS-CoV-2 induces distinct inflammatory signals in cystic fibrosis macrophages that are seduced by resolvins
por: Recchiuti, A., et al.
Publicado: (2021)

Oxylipin profile in saliva from patients with cystic fibrosis reveals a balance between pro-resolving and pro-inflammatory molecules
por: Carnovale, Vincenzo, et al.
Publicado: (2022)

Coil embolisation for massive haemoptysis in cystic fibrosis
por: Dohna, Martha, et al.
Publicado: (2021)

Altered mucosal immune response after acute lung injury in a murine model of Ataxia Telangiectasia
por: Eickmeier, Olaf, et al.
Publicado: (2014)

Pro-Resolving Lipid Mediators in the Pathophysiology of Asthma
por: Kytikova, Oxana, et al.
Publicado: (2019)

Resolvin D1 and D2 reduce SARS‐CoV‐2‐induced inflammatory responses in cystic fibrosis macrophages
por: Recchiuti, Antonio, et al.
Publicado: (2021)

Oil supplementation with a special combination of n-3 and n-6 long-chain polyunsaturated fatty acids does not protect for exercise induced asthma: a double-blind placebo-controlled trial
por: Dreßler, M., et al.
Publicado: (2020)

Therapeutic Effects of Specialized Pro-Resolving Lipids Mediators on Cardiac Fibrosis via NRF2 Activation
por: Kang, Gyeoung Jin, et al.
Publicado: (2020)

Strain-Resolved Dynamics of the Lung Microbiome in Patients with Cystic Fibrosis
por: Dmitrijeva, Marija, et al.
Publicado: (2021)

Cell-Type-Specific Gene Regulatory Networks of Pro-Inflammatory and Pro-Resolving Lipid Mediator Biosynthesis in the Immune System
por: Hoch, Matti, et al.
Publicado: (2023)

Diabetes in Cystic Fibrosis: Multicenter Screening Results Based on Current Guidelines
por: Scheuing, Nicole, et al.
Publicado: (2013)

Resolvins and aliamides: lipid autacoids in ophthalmology – what promise do they hold?
por: Hesselink, Jan M Keppel, et al.
Publicado: (2016)

Glued in lipids: Lipointoxication in cystic fibrosis
por: Vandebrouck, Clarisse, et al.
Publicado: (2020)

Resolvins and inflammatory pain
por: Sommer, Claudia, et al.
Publicado: (2011)

Resolvins on the way to resolution
por: Ward, Peter A.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_7rds11q814ls9ks8c0aiaaumf3